266 related articles for article (PubMed ID: 12204675)
1. The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells.
Kim M; Zinn KR; Barnett BG; Sumerel LA; Krasnykh V; Curiel DT; Douglas JT
Eur J Cancer; 2002 Sep; 38(14):1917-26. PubMed ID: 12204675
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3.
Brüning A; Köhler T; Quist S; Wang-Gohrke S; Moebus VJ; Kreienberg R; Runnebaum IB
Hum Gene Ther; 2001 Mar; 12(4):391-9. PubMed ID: 11242531
[TBL] [Abstract][Full Text] [Related]
3. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.
Kanerva A; Mikheeva GV; Krasnykh V; Coolidge CJ; Lam JT; Mahasreshti PJ; Barker SD; Straughn M; Barnes MN; Alvarez RD; Hemminki A; Curiel DT
Clin Cancer Res; 2002 Jan; 8(1):275-80. PubMed ID: 11801569
[TBL] [Abstract][Full Text] [Related]
4. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy.
Wu H; Han T; Lam JT; Leath CA; Dmitriev I; Kashentseva E; Barnes MN; Alvarez RD; Curiel DT
Gene Ther; 2004 May; 11(10):874-8. PubMed ID: 14999229
[TBL] [Abstract][Full Text] [Related]
6. Liposome-complexed adenoviral gene transfer in cancer cells expressing various levels of coxsackievirus and adenovirus receptor.
Lee EM; Hong SH; Lee YJ; Kang YH; Choi KC; Choi SH; Kim IH; Lim SJ
J Cancer Res Clin Oncol; 2004 Mar; 130(3):169-77. PubMed ID: 14677059
[TBL] [Abstract][Full Text] [Related]
7. In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus.
Hemminki A; Zinn KR; Liu B; Chaudhuri TR; Desmond RA; Rogers BE; Barnes MN; Alvarez RD; Curiel DT
J Natl Cancer Inst; 2002 May; 94(10):741-9. PubMed ID: 12011224
[TBL] [Abstract][Full Text] [Related]
8. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
Nakamura T; Sato K; Hamada H
Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
[TBL] [Abstract][Full Text] [Related]
9. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.
Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS
Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331
[TBL] [Abstract][Full Text] [Related]
10. An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression.
Hemminki A; Belousova N; Zinn KR; Liu B; Wang M; Chaudhuri TR; Rogers BE; Buchsbaum DJ; Siegal GP; Barnes MN; Gomez-Navarro J; Curiel DT; Alvarez RD
Mol Ther; 2001 Sep; 4(3):223-31. PubMed ID: 11545613
[TBL] [Abstract][Full Text] [Related]
11. Tissue-targeted in vivo gene transfer coupled with histone deacetylase inhibitor depsipeptide (FK228) enhances adenoviral infection in rat renal cancer allograft model systems.
Kobayashi M; Okada T; Murakami T; Ozawa K; Kobayashi E; Morita T
Urology; 2007 Dec; 70(6):1230-6. PubMed ID: 18158067
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer to cervical cancer with fiber-modified adenoviruses.
Rein DT; Breidenbach M; Wu H; Han T; Haviv YS; Wang M; Kirby TO; Kawakami Y; Dall P; Alvarez RD; Curiel DT
Int J Cancer; 2004 Sep; 111(5):698-704. PubMed ID: 15252838
[TBL] [Abstract][Full Text] [Related]
13. Targeted adenoviral vectors.
Barnett BG; Crews CJ; Douglas JT
Biochim Biophys Acta; 2002 May; 1575(1-3):1-14. PubMed ID: 12020813
[TBL] [Abstract][Full Text] [Related]
14. Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines.
Pearson AS; Koch PE; Atkinson N; Xiong M; Finberg RW; Roth JA; Fang B
Clin Cancer Res; 1999 Dec; 5(12):4208-13. PubMed ID: 10632362
[TBL] [Abstract][Full Text] [Related]
15. Optimizing cardiovascular gene therapy: increased vascular gene transfer with modified adenoviral vectors.
Kibbe MR; Murdock A; Wickham T; Lizonova A; Kovesdi I; Nie S; Shears L; Billiar TR; Tzeng E
Arch Surg; 2000 Feb; 135(2):191-7. PubMed ID: 10668880
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
Rosenfeld ME; Feng M; Michael SI; Siegal GP; Alvarez RD; Curiel DT
Clin Cancer Res; 1995 Dec; 1(12):1571-80. PubMed ID: 9815958
[TBL] [Abstract][Full Text] [Related]
17. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
Li D; Duan L; Freimuth P; O'Malley BW
Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
[TBL] [Abstract][Full Text] [Related]
18. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector.
Kasono K; Blackwell JL; Douglas JT; Dmitriev I; Strong TV; Reynolds P; Kropf DA; Carroll WR; Peters GE; Bucy RP; Curiel DT; Krasnykh V
Clin Cancer Res; 1999 Sep; 5(9):2571-9. PubMed ID: 10499635
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the adenoviral sensitivity of human ovarian cancer cells by transient expression of coxsackievirus and adenovirus receptor (CAR).
Kim JS; Lee SH; Cho YS; Choi JJ; Kim YH; Lee JH
Gynecol Oncol; 2002 May; 85(2):260-5. PubMed ID: 11972385
[TBL] [Abstract][Full Text] [Related]
20. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.
Qin M; Chen S; Yu T; Escuadro B; Sharma S; Batra RK
Clin Cancer Res; 2003 Oct; 9(13):4992-9. PubMed ID: 14581374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
